Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q2 2025 · 10-Q
Revenue—
Net Income-$2.74M-$2.74MN/M vs Q2 2024 EPS Diluted-$2.15-$2.15N/M vs Q2 2024 Operating Income-$2,767,864N/M Operating Cash Flowderived-$2,951,389N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,968,720N/M ended Jun 30, 2025 · filed Aug 5, 2025 · 36 d after period end